Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Summing it up While GLP-1 medications offer benefits for weight loss and blood sugar control that may indirectly help with fertility, their direct impact on IVF outcomes and safety during pregnancy needs further research
Retatrutide, a triple hormone agonist targeting GIP, GLP-1, and glucagon receptors, has shown promising early results that may exceed Mounjaro in some measures
As GLP-1 medications continue to expand beyond diabetes treatment and become increasingly common for weight management, Kaestner believes more research will be needed to understand whether their broader social effects become more apparent in other populations or over longer periods of time
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study
This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
US$ 20.83
US$ 26.94
US$ 24.47
US$ 25.21
US$ 27.96
